Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor II

Epithelial ovarian carcinoma (EOC) is the most prevalent and lethal form of ovarian cancer. The low five-year overall survival after EOC diagnosis indicates an urgent need for more effective ways to control this disease. Anti-Müllerian hormone receptor 2 (AMHR2) is an ovarian protein overexpressed i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazumder, Suparna, Swank, Valerie, Komar, Anton A., Johnson, Justin M., Tuohy, Vincent K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244012/
https://www.ncbi.nlm.nih.gov/pubmed/32499873
http://dx.doi.org/10.18632/oncotarget.27585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244012/
https://www.ncbi.nlm.nih.gov/pubmed/32499873
http://dx.doi.org/10.18632/oncotarget.27585

Ejemplares similares